PhaseBio Pharmaceuticals Inc·4

May 21, 6:27 PM ET

Mow Jonathan P 4

4 · PhaseBio Pharmaceuticals Inc · Filed May 21, 2019

Insider Transaction Report

Form 4
Period: 2019-05-17
Mow Jonathan P
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-05-17$2.27/sh+19,913$45,20371,112 total
  • Exercise/Conversion

    Common Stock

    2019-05-20$1.24/sh+19,131$23,72290,243 total
  • Exercise/Conversion

    Employee stock option (right to buy)

    2019-05-1719,9130 total
    Exercise: $2.27From: 2016-12-03Exp: 2022-12-21Common Stock (19,913 underlying)
  • Exercise/Conversion

    Employee stock option (right to buy)

    2019-05-2019,1310 total
    Exercise: $1.24From: 2018-03-14Exp: 2024-03-31Common Stock (19,131 underlying)

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION